Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734666 · ClinicalTrials.gov registry record · NA
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
A NA study of Tobacco Use and Alcohol Use, Unspecified, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT03734666: Completed NA study of Tobacco Use and Alcohol Use, Unspecified, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT03734666 is a NA study of Tobacco Use and Alcohol Use, Unspecified that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 67 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03734666, a NA study of Tobacco Use and Alcohol Use, Unspecified, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.
Primary Outcome
Number of participants scoring \>3. Patient satisfaction will be determined through a score on the Client Satisfaction Questionnaire Version 8 (Attkinson \& Greenfield), where participants respond to 8 items on a 4-point scale (1=very dissatisfied; 4=very satisfied). Results reported indicate clients with a patient satisfaction score over 80%.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Mindfulness Based Relapse Prevention - Smoking and Alcohol
Study Locations (1)
Florida
- H Lee Moffitt Cancer Center and Research Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-01-14 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
What the finished NCT03734666 record still lists
NCT03734666 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT03734666 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03734666 about?
NCT03734666 is a clinical study titled "Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation". The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.
What is the current status of trial NCT03734666?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-01-14. Estimated completion is 2021-11-04.
What conditions does trial NCT03734666 study?
This clinical trial studies the following conditions: Tobacco Use, Alcohol Use, Unspecified.
What interventions are being tested in trial NCT03734666?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Mindfulness Based Relapse Prevention - Smoking and Alcohol (BEHAVIORAL).
Who is sponsoring clinical trial NCT03734666?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03734666 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03734666's enrollment target sits among peer trials
67 44th of 76 higher than 33 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI